Search results
BIOPHEN Antithrombin LRT (anti-Xa, Liquid Reagent Technology)
Diagnosis of congenital or acquired antithrombin deficiencies.
BIOPHEN Antithrombin 5 (anti-Xa)
Diagnosis of congenital or acquired antithrombin deficiencies. Measurement of AT activity in biological milieu or purified fractions.
BIOPHEN Antithrombin 2.5 (Anti-Xa)
Diagnosis of congenital or acquired antithrombin deficiencies. Measurement of AT activity in biological milieu or purified fractions.
BIOPHEN DiXaI (Direct Xa Inhibitors)
Measurement of rivaroxaban and other factor Xa inhibitors in citrated plasma or other biological fluids. Note: BIOPHEN Heparin LRT and BIOPHEN Heparin (3 or 6) can also be used for testing direct factor Xa inhibitors (DiXaIs), such as rivaroxaban, apixaban or edoxaban. Adjusted protocols are available on demand.
BIOPHEN Heparin anti-IIa (2-stages) -> SEE NEW REF. 220005
Assay proposed for the measurement of heparin anti-thrombin activity in research applications acc. to Pharmacopoeia.
BIOPHEN Heparin anti-IIa (Kinetics)
Assay proposed for the measurement of heparin in research applications.
BIOPHEN Heparin LRT 5 (Liquid Reagent Technology)
Measuring the concentration of UFH, LMWH, Arixtra®, Orgaran®, rivaroxaban (Xarelto®), apixaban (Eliquis®) and edoxaban (Lixiana®) in patients’ plasma for monitoring the therapy and adjusting drug dosage.
BIOPHEN Heparin LRT 3 (Liquid Reagent Technology)
Measuring the concentration of UFH, LMWH, Arixtra®, Orgaran®, rivaroxaban (Xarelto®), apixaban (Eliquis®) and edoxaban (Lixiana®) in patients’ plasma for monitoring the therapy and adjusting drug dosage.
BIOPHEN Heparin LRT 7.5 (Liquid Reagent Technology)
Measuring the concentration of UFH, LMWH, Arixtra®, Orgaran®, rivaroxaban (Xarelto®), apixaban (Eliquis®) and edoxaban (Lixiana®) in patients’ plasma for monitoring the therapy and adjusting drug dosage.
BIOPHEN Heparin (anti-Xa, 2-stages kit) -> SEE NEW REF. 221005
Assay proposed for the measurement of anti-Xa heparin activity in research applications. This assay meets USP/EP requirements.